http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-080982-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b70512b2076a2759fccaecf9fe962d5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
filingDate 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-080982-A1
titleOfInvention QUINOXALINE DERIVATIVES
abstract Pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and the use of said compounds in the treatment of diseases, for example, cancer. Claim 1: A compound of the formula (1) including any tautomeric or stereochemically isomeric form thereof, wherein n represents an integer equal to 0, 1, 2, 3 or 4; R 1 represents hydrogen, C 1-6 alkyl, C 2-4 alkenyl, C 1-6 hydroxyalkyl, C 1-6 haloalkyl, C 1-6 hydroxyhaloalkyl, C 1-4 cyanoalkyl, C 1-6 alkoxy-C 1-6 alkyl, wherein each C 1-6 alkyl 6 may be optionally substituted with one or two hydroxyl groups, C1-6 alkyl substituted with -NR4R5, C1-6 alkyl substituted with -C (= O) -NR4R5, -S (= O) 2-C1-6 alkyl, - S (= O) 2-C1-6 haloalkyl, -S (= O) 2-NR14R15, C1-6 alkyl substituted with -S (= O) 2-C1-6 alkyl, C1-6 alkyl substituted with -S ( = O) 2-halo C1-6 alkyl, C1-6 alkyl substituted with -S (= O) 2-NR14R15, C1-6 alkyl substituted with -NH-S (= O) 2-C1-6 alkyl, C1- alkyl 6 substituted with -NH-S (= O) 2-C1-6 haloalkyl, C1-6 alkyl substituted with -NR12-S (= O) 2-NR14R15, R6, C1-6 alkyl substituted with R6, C1-6 alkyl substituted with -C (= O) -R6, C1-6 hydroxyalkyl substituted with R6, C1-6 alkyl substituted with -Si (CH3) 3, C1-6 alkyl substituted with -P (= O) (OH) 2 or alkyl C1-6 substituted with -P (= O) (C1-6 alkyl) 2; each R1a is independently selected from hydrogen, C1-4 alkyl, C1-4 hydroxyalkyl, C1-4 alkyl substituted with amino or mono- or di (C1-4 alkyl) amino or -NH (C3-8 cycloalkyl) , C1-4 cyanoalkyl, C1-4 alkoxy-C1-4 alkyl and C1-4 alkyl substituted with one or more fluorine atoms; each R2 is independently selected from hydroxyl, halogen, cyano, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxy, C1-4 hydroxyalkyl, C1-4 hydroxyalkoxy, C1-4 haloalkyl , C1-4 haloalkoxy, C1-4 hydroxyhaloalkyl, C1-4 hydroxyhaloalkoxy, C1-4 alkoxy-C1-4 alkyl, C1-4 haloalkoxy-C1-4 alkyl, C1-4 alkoxy-C1-4 alkyl, wherein each alkyl C1-4 may be optionally substituted with one or two hydroxyl groups, hydroxyhaloalkoxy C1-4-C1-4 alkyl, R13, C1-4 alkyl substituted with R13, C1-4 alkyl substituted with -C (= O) -R13, alkoxy C1-4 substituted with R13, C1-4 alkoxy substituted with -C (= O) -R13, -C (= O) -R13, C1-4 alkyl substituted with -NR7R8, C1-4 alkyl substituted with -C (= O) -NR7R8, C1-4 alkoxy substituted with -NR7R8, C1-4 alkoxy substituted with -C (= O) -NR7R8, -NR7R8 and -C (= O) -NR7R8, or when two R2 groups are attached to atoms adjacent carbon, can be taken together to form a radical of the formula -O- (C (R17) 2) pO-; -X-CH = CH-; or -X-CH = N-; wherein R17 represents hydrogen or fluorine, p represents 1 or 2 and X represents O or S; R3 represents hydroxyl, C1-6 alkoxy, C1-6 hydroxyalkoxy, C1-6 alkoxy substituted with -NR10R11, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl optionally substituted with -OC (= O ) -C 1-6 alkyl, C 1-6 hydroxyalkyl optionally substituted with -OC (= O) -C 1-6 alkyl, C 2-6 hydroxyalkenyl, C 2-6 hydroxyalkynyl, C 1-6 hydroxyhaloalkyl, C 1-6 cyanoalkyl, C 1-6 alkyl carboxyl substituted, C1-6 alkyl substituted with -C (= O) -C1-6 alkyl, C1-6 alkyl substituted with -C (= O) -O-C1-6 alkyl, C1-6 alkyl substituted with C1 alkoxy -6-C1-6-OC alkyl (= O) -, C1-6 alkyl substituted with C1-6 alkoxy-C1-6-C alkyl (= O) -, C1-6 alkyl substituted with -OC (= O) -C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, wherein each C1-6 alkyl can be optionally substituted with one or two hydroxyl groups or with -OC (= O) -C1-6 alkyl, C2 alkenyl 6 substituted with C1-6 alkoxy, C2-6 alkynyl substituted with C1-6 alkoxy, C1-6 alkyl substituted with R9 and optionally substituted with -OC (= O) -C alkyl 1-6, C1-6 alkyl substituted with -C (= O) -R9, C1-6 alkyl substituted with hydroxyl and R9, C2-6 alkenyl substituted with R9, C2-6 alkynyl substituted with R9, C1-6 alkyl substituted with -NR10R11, C2-6 alkenyl substituted with -NR10R11, C2-6 alkynyl substituted with -NR10R11, C1-6 alkyl substituted with hydroxyl and -NR10R11, C1-6 alkyl substituted with one or two halogens and -NR10R11, -C1 alkyl -6-C (R12) = NO-R12, C1-6 alkyl substituted with -C (= O) -NR10R11, C1-6 alkyl substituted with -OC (= O) -NR10R11, -S (= O) 2- C1-6 alkyl, -S (= O) 2-C1-6 haloalkyl, -S (= O) 2-NR14R15, C1-6 alkyl substituted with -S (= O) 2-C1-6 alkyl, C1- alkyl 6 substituted with -S (= O) 2-halo C1-6 alkyl, C1-6 alkyl substituted with -S (= O) 2-NR14R15, C1-6 alkyl substituted with -NR12-S (= O) 2-C1 alkyl -6, C1-6 alkyl substituted with -NH-S (= O) 2-haloalkyl C1-6, C1-6 alkyl substituted with -NR12-S (= O) 2-NR14R15, R13, C1-6 alkyl substituted with -P (= O) (OH) 2 or C1-6 alkyl substituted with -P (= O) (C1-6 alkyl) 2; R4 and R5 each independently represent hydrogen, C1-6 alkyl, C1-6 hydroxyalkyl, C1-6 haloalkyl, C1-6 hydroxyhaloalkyl, C1-6 alkoxy where each C1-6 alkyl can be optionally substituted with one or two hydroxyl groups, -S (= O) 2-C1-6 alkyl, -S (= O) 2-C1-6 haloalkyl, -S (= O) 2-NR14R15, C1-6 alkyl substituted with - S (= O) 2-C1-6 alkyl, C1-6 alkyl substituted with -S (= O) 2-C1-6 haloalkyl, C1-6 alkyl substituted with -S (= O) 2-NR14R15, C1- alkyl 6 substituted with -NH-S (= O) 2-C1-6 alkyl, C1-6 alkyl substituted with -NH-S (= O) 2-C1-6 haloalkyl, C1-6 alkyl substituted with -NH-S ( = O) 2-NR14R15, R13 or C1-6 alkyl substituted with R13; R 6 represents C 3-8 cycloalkyl, C 3-8 cycloalkenyl, phenyl, 4- to 7-membered monocyclic heterocyclyl containing at least one heteroatom selected from N, O or S; said C3-8 cycloalkyl, C3-8 cycloalkenyl, phenyl, 4- to 7-membered monocyclic heterocyclyl, optionally and, independently, each substituted with 1, 2, 3, 4 or 5 substituents, each substituent being independently selected cyano, C1-6 alkyl, C1-6 cyanoalkyl, hydroxyl, carboxyl, C1-6 hydroxyalkyl, halogen, C1-6 haloalkyl, hydroxyhaloalkyl C1-6, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, alkyl C16-OC (= O) -, -NR14R15, -C (= O) -NR14R15, C1-6 alkyl substituted with -NR14R15, C1-6 alkyl substituted with -C (= O) -NR14R15, -S (= O ) 2-C1-6 alkyl, -S (= O) 2- C1-6 haloalkyl, -S (= O) 2-NR14R15, C1-6 alkyl substituted with -S (= O) 2-C1-6 alkyl, C1-6 alkyl substituted with -S (= O) 2-haloalkyl C1-6, C 1-6 alkyl substituted with -S (= O) 2-NR4R15, C1-6 alkyl substituted with -NH-S (= O) 2- C1-6 alkyl, C1-6 alkyl substituted with -NH-S (= O) 2-C1-6 haloalkyl or C1-6 alkyl substituted with -NH-S (= O) 2-NR14R15; R 7 and R 8 each independently represent hydrogen, C 1-6 alkyl, C 1-6 hydroxyalkyl, C 1-6 haloalkyl, C 1-6 hydroxyhaloalkyl or C 1-6 alkoxy-C 1-6 alkyl; R9 represents C3-8 cycloalkyl, C3-8 cycloalkenyl, phenyl, naphthyl or 3- or 12-membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O or S, said C3-8 cycloalkyl being, C3-8 cycloalkenyl , phenyl, naphthyl or monocyclic or bicyclic heterocyclyl of 3 to 12 members optionally and independently substituted with 1, 2, 3, 4 or 5 substituents, each substituent being independently selected from = O, C 1-4 alkyl, hydroxyl, carboxyl, C1-4 hydroxyalkyl, cyano, C1-4 cyanoalkyl, C1-4-OC alkyl (= O) -, C1-4 alkyl substituted with C1-4-alkyl (= O) -, C1-4-C alkyl (= O) -, C1-4 alkoxy-C1-4 alkyl, wherein each C1-4 alkyl may be optionally substituted with one or two hydroxyl, halogen, C1-4 haloalkyl, C1-4 hydroxyhaloalkyl groups, -NR14R15, -C ( = O) -NR14R15, C1-4 alkyl substituted with -NR14R15, C1-4 alkyl substituted with -C (= O) -NR14R15, C1-4 alkoxy, -S (= O) 2-C1-4 alkyl, -S (= O) 2-C1-4 haloalkyl, -S (= O) 2-NR14 R15, C1-4 alkyl substituted with -S (= O) 2-NR14R15, C1-4 alkyl substituted with -NH-S (= O) 2-C1-4 alkyl, C1-4 alkyl substituted with - NH-S ( = O) 2-haloC 1-4 alkyl, C1-4 alkyl substituted with -NH-S (= O) 2-NR14R15, R13, -C (= O) -R13, C1-4 alkyl substituted with R13, optionally substituted phenyl with R16, C1-6 phenylalkyl, wherein the phenyl is optionally substituted with R16, a 5 or 6 membered monocyclic aromatic heterocyclyl containing at least one heteroatom selected from N, O or S wherein said heterocyclyl is optionally substituted with R16; or when two of the R9 substituents are attached to the same atom, they can be taken together to form a 4- to 7-membered saturated monocyclic heterocyclyl containing at least one heteroatom selected from N, O or S; R10 and R11 each independently represent hydrogen, carboxyl, C1-6 alkyl, C1-6 cyanoalkyl, C1-6 alkyl substituted with -NR14R15, C1-6 alkyl substituted with -C (= O) -NR14R15, haloalkyl C 1-6, C 1-6 hydroxyalkyl, C 1-6 hydroxyhaloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkyl, wherein each C 1-6 alkyl can be optionally substituted with one or two hydroxyl groups, R 6, alkyl C1-6 substituted with R6, -C (= O) -R6, -C (= O) -C1-6 alkyl, -C (= O) -hydroxyalkyl C1-6, -C (= O) -haloalkyl C1- 6, -C (= O) - C1-6 hydroxyhaloalkyl, C1-6 alkyl substituted with -Si (CH3) 3, -S (= O) 2-C1-6 alkyl, -S (= O) 2-haloalkyl C1 -6, -S (= O) 2-NR14R15, C1-6 alkyl substituted with -S (= O) 2-C1-6 alkyl, C1-6 alkyl substituted with -S (= O) 2-C1-6 haloalkyl , C1-6 alkyl substituted with -S (= O) 2-NR14R15, C1-6 alkyl substituted with -NH-S (= O) 2-C1-6 alkyl, C1-6 alkyl substituted with -NH-S (= O) 2-haloC 1-6 alkyl or C 1-6 alkyl substituted with -NH-S (= O) 2-NR14R15; R12 represents hydrogen or C1-4 alkyl optionally substituted with C1-4 alkoxy; R13 represents C3-8 cycloalkyl or a 4 to 6 membered saturated monocyclic heterocyclyl containing at least one heteroatom selected from N, O or S, wherein said C3-8 cycloalkyl or monocyclic heterocyclyl is optionally substituted with 1, 2 or 3 substituents each independently selected from halogen, hydroxyl, C1-6 alkyl, -C (= O) -C 1-6 alkyl, C1-6 alkoxy or -NR14R15; R14 and R15 each independently represent hydrogen or C1-4 haloalkyl or C1-4 alkyl optionally substituted with a substitute
priorityDate 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 60.